id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2024-D-2033-0054,FDA,FDA-2024-D-2033,Agency Information Collection Activities; Proposed Collection; Comment Request; Expedited Programs for Serious Conditions—Accelerated Approval of Drugs and Biologics,Notice,60 Day Proposed Information Collection,2026-02-06T05:00:00Z,2026,2,2026-02-06T05:00:00Z,2026-04-08T03:59:59Z,2026-02-06T19:55:42Z,2026-02386,1,0,09000064b9195c65